HCA Healthcare, Inc.
HCA · Price history
Price at last available close
$463.22
+$30.62 (+7.08%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About HCA Healthcare, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 8, 2026. A research update is not a new financial filing.
Who they are
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy.
How they make money
HCA Healthcare operates a network of hospitals and related health care facilities. The company generates revenue primarily by providing inpatient and outpatient medical services to patients, with payments received from government programs like Medicare and Medicaid, as well as private health insurance plans and individual patients.
Products & services
General and acute care hospitals, behavioral health hospitals, rehabilitation hospitals, freestanding surgery centers, and various other outpatient health care facilities.
Brands & revenue mix
The primary corporate brand under which the company's facilities operate.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer types
Customer concentration
The company does not disclose specific customer concentration, but notes that a significant portion of its revenue is derived from government-sponsored health care programs, specifically Medicare and Medicaid, as of the fiscal year ended December 31, 2025.
Suppliers, materials & equipment
- Medical supply and pharmaceutical distributors — The company relies on various third-party vendors for medical supplies, pharmaceuticals, and equipment; specific supplier names are not disclosed.Source
Competitors
- Community Health Systems, Inc. — Operates general acute care hospitals and outpatient facilities in the United States.Source
- Tenet Healthcare Corporation — Provides health care services through a network of hospitals and outpatient centers.Source
- Universal Health Services, Inc. — Operates acute care hospitals and behavioral health facilities.Source
Strengths
Sources
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
50
Fair
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
62
Fair
Financial Strength
50
Business Quality / Moat
98
Management
50
Growth Quality
33
Risk / Durability
76
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
65
Fully Valued
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
61/100
Building Historical Record
Model Score 61/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as moderate rather than unusually attractive.
The model outlook is currently moderate.
- •Valuation scores attractively
- •Recent buyback activity is present
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for HCA
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can HCA maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is HCA's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Is HCA's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •Is HCA's valuation discount tied to a temporary concern or to a longer-term business risk?
Essential Investment Snapshot
Wall Street Score
50
Opportunity Score
65
Market Cap
$100.29B
P/E Ratio
15.7
EPS
$29.96
52-Week High
$556.52
52-Week Low
$353.99
Beta
1.11
Intrinsic Value
$726.16
Analyst Target
$476.00
Shares Outstanding
230.7M
Total Revenue
$78.01B
Total Debt
$48.78B
Reported Dividend Yield
0.67%
Liquidation Value / Share
$-13.62
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Building upward momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for HCA
Detected from reported data — verify before acting.Dividend history reported
The provider reports a dividend yield. Confirm the latest declaration before treating it as a current payment.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total callsNo personal call yet on HCA.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Large-scale geographic footprint and diversified facility network.
- +Significant investment in clinical technology and data analytics.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Care Facilities industry.
- −Changes in government reimbursement rates and regulations.
- −Labor shortages and rising costs for clinical staff.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
6 historical score records availablePrevious Score
50
Oct 23, 2026
Change
-0.1
points
Current Score
50
Oct 24, 2026
Category Changes
HCA decreased 0.1 points because some fundamentals weakened.
Projected Score
Projected Score
49
Projected Change
-0.8 points
Preliminary comparable-period financial changes suggest decline of approximately 0.8 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
UndervaluedCurrent Price
$463.22
Model Intrinsic Value
$726.16
Difference
−$262.94
-36.2% vs IV
Margin of Safety
36.2%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $78.01B | $75.60B | $70.60B | $64.97B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $55.89B | $44.23B | $41.92B | $39.39B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $22.12B | $31.37B | $28.68B | $25.58B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $16.57B | $8.00B | $31.17B | $29.49B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $10.05B | $19.41B | $18.13B | $15.95B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $15.84B | $15.60B | $13.90B | $12.72B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $12.07B | $11.96B | $10.55B | $9.63B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $2.32B | $2.25B | $2.06B | $1.94B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | $9.87B | $9.83B | $8.52B | $7.71B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $2.02B | $2.05B | $1.87B | $1.61B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | $6.84B | $6.78B | $5.76B | $5.24B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $29.96 | $28.62 | $22.27 | $19.24 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 223M | 231M | 259M | 272M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 223M | 231M | 262M | 276M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$20.23B
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$7.62
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
+5.2%
Cash Change
+7.9%
Margin Change
-0.5 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Cash position grew
What Weakened
- Margins contracted
- Debt increased
Potential Score Impact
Positive indicators included revenue growth, EPS growth, cash levels. Pressure indicators included debt levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 8.7%. EPS increased 11.6%. Cash increased 7.9%. Total debt increased 5.2%. Net income margin declined by 0.5 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
56
Smart Money
56
Number of Gurus
5
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
A dividend is reported, but detailed payment history is temporarily unavailable or awaiting refresh.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
6 historical recordsHistorical Score Chart
3 of 6 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Care FacilitiesNews
HCA Healthcare: Payer Mix Pressures, But Broad Trends On Track
HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results
HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Rumor Mill · HCA
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial